Viridian Therapeutics, Inc. company logo
Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc. (VRDN) Cash From Financing

Annual CFF

$457.74M$232.07M+102.83%

Summary

Current Value
As of today, VRDN annual cash from financing is $457.74M, up +102.83% on
Historical Performance
VRDN annual cash from financing is up +265.39% over the past 3 years, and up +653810.00% over the past 5 years
All-Time High Comparison
VRDN annual cash from financing is currently at its all-time high
3-Year Low Comparison
VRDN annual cash from financing is +102.83% above its 3-year low of $225.67M reached on
Sector Comparison
VRDN annual cash from financing is higher than 96.27% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

VRDN Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$457.74M+102.8%+265.4%+10000.0%+7784.4%
Quarterly Cash From Financing$10.86M-95.6%+133.7%
TTM Cash From Financing$56.36M-90.9%+130.8%
Price$30.57+46.2%+11.3%+66.1%
Annual Cash From Operations-$232.32M-26.1%-325.6%-544.3%-3632.2%
Annual Cash From Investing-$228.65M-142.6%-207.8%-910.1%-10000.0%
Annual Dividends Paid$0.000.0%0.0%0.0%-100.0%
Annual Total Debt$23.10M+4.8%+2120.7%+178.1%+2.1%
Shares Outstanding95.44M+17.8%+131.1%+2155.7%

Cash From Financing Highs

VRDN Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$457.74Mat high
5Y$457.74Mat high
All$457.74Mat high

Cash From Financing Lows

VRDN Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y$225.67M+102.8%
5Y$101.31MN/A+351.8%
All-$257.00K>+9999.0%

Cash From Financing History

YearValueChange
$457.74M+102.8%
$225.67M-30.0%
$322.24M+157.2%
$125.28M+23.7%
$101.31M>+9,900.0%
$70.00K-99.8%
YearValueChange
$41.92M-20.1%
$52.47M>+9,900.0%
-$257.00K-102.0%
$12.71M+71.8%
$7.40M-

FAQ

  • What is the current annual cash from financing of VRDN?

    As of today, VRDN annual cash from financing is $457.74M

  • What is 1-year change in VRDN annual cash from financing?

    VRDN annual cash from financing is up +102.83% year-over-year

  • What is 3-year change in VRDN annual cash from financing?

    VRDN annual cash from financing is up +265.39% over the past 3 years

  • How far is VRDN annual cash from financing from its all-time high?

    VRDN annual cash from financing is currently at its all-time high

  • How does VRDN annual cash from financing rank versus sector peers?

    VRDN annual cash from financing is higher than 96.27% of companies in Healthcare sector

  • When is VRDN next annual earnings release?

    The next annual earnings release for VRDN is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. VRDN Official Website www.viridiantherapeutics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1590750/000159075025000020/0001590750-25-000020-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1590750/000159075025000004/0001590750-25-000004-index.htm
  4. VRDN Profile on Yahoo Finance finance.yahoo.com/quote/VRDN
  5. VRDN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrdn